The Weekly Roundup: April 21-25

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Keratin Hair Treatments and Formaldehyde Exposure

Keratin hair treatments straighten, smooth, and add shine—though formaldehyde risks raise safety concerns for dermatologists and salon professionals.

AD Misconceptions with Peter Lio, MD

While dietary changes can help slightly, they’re not a cure-all for most patients with AD.

The Future of AI-Powered Skincare

Anastasia Georgievskaya reflects on the success of SkinGPT and reveals upcoming plans and potential advancements in artificial intelligence and dermatology.

Andrew Baker, MBA, MPAS, PA-C, Shares Vision for SDPA Leadership

Strengthening interdisciplinary relationships remains a central part of Baker’s focus.

Newly Developed REACH Score Identifies Burden for Employed Patients with Chronic Wounds

Nearly half of the surveyed patients identified a negative impact of their wounds on daily life, particularly at work.

Understanding the Role of the Microbiome in Rosacea

Over the past few years, research on the microbiome and dysbiosis has gained interest in the potential exacerbation of several skin diseases, including rosacea.

Survey Unveils Impact of Chronic Hand Eczema on Patients’ Lives and Treatment Landscape

A survey by LEO Pharma indicates widespread misunderstandings about chronic hand eczema, revealing significant emotional and occupational challenges for patients.

Palvella Secures New US Patent for Qtorin Rapamycin in Microcystic Lymphatic Malformations

Palvella has secured its 5th US patent for Qtorin rapamycin, extending intellectual property coverage to 2038 and advancing treatment for microcystic lymphatic malformations.

Teledermatology Preferences Among Patients with Psoriasis

Continuity with a known physician and rapid response times significantly increased patient willingness to use teledermatology.

Redefining Anti-Aging with Regenerative Aesthetics and Growth Factor Skincare

Prithwiraj Maitra, PhD, Vice President of Global Skincare R&D at Allergan Aesthetics, gave his thoughts on regenerative aesthetics and other recent skincare advancements.

Isotretinoin Often Continued Despite Mood Concerns

Despite early psychological symptoms, over half of patients in the study completed their full treatment course.

Using Real-World AD Cases to Pick the Right Therapy for Each Patient

In a recent Dermatology Times Case-Based Peer Perspectives custom video series, Naiem Issa, MD, PhD, reviewed 3 complex patient cases of atopic dermatitis.

Minocycline Foam Significantly Improves Papulopustular Rosacea Outcomes

Researchers conducted a review to understand the efficacy and safety of topical minocycline for the treatment of moderate to severe papulopustular rosacea.

Journal Digest: April 23

This review of the latest dermatologic studies includes insights into epidermolysis bullosa for primary care providers, patient-reported impact of atopic dermatitis on pediatric and adolescent patients, and more.

Dual-Energy Approach Boosts Skin Hydration

Recent research investigates a novel technology that shifts the paradigm—utilizing a dual-energy approach combining monopolar radiofrequency (RF) with targeted ultrasound (TUS) to induce in situ HA synthesis.

What Dermatologists Need to Know About the Future of Regenerative Aesthetics

While products like growth factor skincare already have demonstrated benefits, this is only the beginning, according to Prithwiraj Maitra, PhD.

New Insights into Biologic Therapies for BP

Complete remission was achieved in over 87% of dupilumab users and 64% of omalizumab users.

Understanding Chronic Hand Eczema: Cellular Mechanisms and Therapeutic Implications

Omar Noor, MD, FAAD, explores the complex immune and cellular mechanisms behind CHE and highlights its significant physical and emotional toll on patients.

JAK Inhibitors as Flexible, Fast-Acting Option for Refractory AD

Raj Chovatiya, MD, PhD, MSCI, provides insights on the clinical advantages of JAK inhibitors for atopic dermatitis.

Amy Paller, MD, MS, Discusses Phase 3 Trial Results for Qtorin 3.9% Rapamycin Gel

Paller discusses the promising phase 3 trial SELVA trial results for Qtorin 3.9% rapamycin gel, an investigative treatment for microcystic lymphatic malformations.

Exclusive: Outgoing AAD President Seemal Desai, MD, FAAD, on the 3 Issues That Will Shape Dermatology in 2025 (& Beyond)

Dermatology undergoes rapid transformation with new therapies, but faces challenges in payment reform, certification awareness, and balancing technology with patient care.

Poly-l-Lysine Biovectors with Vitamins A and C Effective for Atopic Dermatitis

DLQI score reduced by 61.8% and SCORAD score reduced by 41.8% in patients after 28 days of treatment.

AbbVie Files BLA for TrenibotE in Glabellar Lines

AbbVie seeks FDA approval for TrenibotE, a first-in-class botulinum toxin offering fast onset and short duration for glabellar lines.

Managing Wound Risks in Patients on TKIs

Explore how tyrosine kinase inhibitors hinder wound healing, revealing critical insights for clinicians in dermatology and oncology.

Upadacitinib Outpaces Dupilumab in Rapid AD Symptom Control

Discover how upadacitinib outperforms dupilumab in providing rapid itch relief for moderate-to-severe atopic dermatitis in a recent AAD study.

Novel Microneedle Radiofrequency Device is Safe for Horizontal Neck Wrinkles

A pilot study reveals a dual-length microneedle RF device effectively reduces neck wrinkles by 35%, enhancing skin hydration and elasticity with minimal downtime.

Stopping Adjuvant Immunotherapy Early May Not Worsen Outcomes in Resected Metastatic Melanoma

New research reveals that early discontinuation of adjuvant immunotherapy for melanoma does not lead to worse outcomes.

Christopher Bunick, MD, PhD, Previews RAD 2025: Raising the Bar in Atopic Dermatitis Care

Discover how the RAD conference in Nashville enhances atopic dermatitis care, featuring expert insights and patient-focused strategies for clinicians.

FDA Places Clinical Hold on VYNE’s VYN202 Phase 1b Trial for Plaque Psoriasis

VYNE Therapeutics paused its VYN202 trial for psoriasis due to an FDA-issued clinical hold.

Deuruxolitinib is Most Effective Monotherapy for Alopecia, According to Meta-Analysis

A recent meta-analysis evaluates the efficacy and safety of various JAK inhibitors for alopecia areata, highlighting 12 mg twice daily deuruxolitinib as the most effective treatment.

Hyaluronic Acid Boosts Results in Rosacea Management

Discover innovative rosacea treatments combining injectable hyaluronic acid with traditional therapies to enhance skin health and boost patient confidence.

Can Colloidal Oat Emollients Be Used to Treat Pediatric Atopic Dermatitis?

Sophisticated colloidal oat emollients show promise in effectively managing pediatric atopic dermatitis, enhancing skin hydration and reducing flare-ups in infants.

Xerosis Management: Back to Basics with Emollients

Explore the effectiveness of basic emollients in treating xerosis cutis associated with atopic dermatitis, enhancing skin hydration and barrier function.